Literature DB >> 15635761

Melatonin for treatment of sleep disorders.

N Buscemi, B Vandermeer, R Pandya, N Hooton, L Tjosvold, L Hartling, G Baker, S Vohra, T Klassen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15635761      PMCID： PMC4781368          DOI： 10.1037/e439412005-001

Source DB:  PubMed          Journal:  Evid Rep Technol Assess (Summ)        ISSN： 1530-440X


× No keyword cloud information.
  20 in total

1.  Pharmacological Treatment of Insomnia.

Authors:  Janette D Lie; Kristie N Tu; Diana D Shen; Bonnie M Wong
Journal:  P T       Date:  2015-11

2.  What is the role of melatonin in the management of sleep disorders in children?

Authors:  Nina Buscemi; Manisha Witmans
Journal:  Paediatr Child Health       Date:  2006-10       Impact factor: 2.253

Review 3.  Yeast factories for the production of aromatic compounds: from building blocks to plant secondary metabolites.

Authors:  Miguel Suástegui; Zengyi Shao
Journal:  J Ind Microbiol Biotechnol       Date:  2016-08-31       Impact factor: 3.346

Review 4.  Management of anxiety and sleep disorders: role of complementary and alternative medicine and challenges of integration with conventional orthodox care.

Authors:  Martins Ekor; Oluyomi S Adeyemi; Chiagoziem A Otuechere
Journal:  Chin J Integr Med       Date:  2012-12-29       Impact factor: 1.978

Review 5.  Adverse Events Associated with Melatonin for the Treatment of Primary or Secondary Sleep Disorders: A Systematic Review.

Authors:  Frank M C Besag; Michael J Vasey; Kim S J Lao; Ian C K Wong
Journal:  CNS Drugs       Date:  2019-12       Impact factor: 5.749

6.  The efficacy and safety of exogenous melatonin for primary sleep disorders. A meta-analysis.

Authors:  Nina Buscemi; Ben Vandermeer; Nicola Hooton; Rena Pandya; Lisa Tjosvold; Lisa Hartling; Glen Baker; Terry P Klassen; Sunita Vohra
Journal:  J Gen Intern Med       Date:  2005-12       Impact factor: 5.128

Review 7.  The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the non-motor symptoms of Parkinson's disease.

Authors:  Klaus Seppi; Daniel Weintraub; Miguel Coelho; Santiago Perez-Lloret; Susan H Fox; Regina Katzenschlager; Eva-Maria Hametner; Werner Poewe; Olivier Rascol; Christopher G Goetz; Cristina Sampaio
Journal:  Mov Disord       Date:  2011-10       Impact factor: 10.338

8.  A metabolomic perspective of melatonin metabolism in the mouse.

Authors:  Xiaochao Ma; Chi Chen; Kristopher W Krausz; Jeffrey R Idle; Frank J Gonzalez
Journal:  Endocrinology       Date:  2008-01-10       Impact factor: 4.736

Review 9.  The Pathophysiologic Role of Disrupted Circadian and Neuroendocrine Rhythms in Breast Carcinogenesis.

Authors:  Lonnele J Ball; Oxana Palesh; Lance J Kriegsfeld
Journal:  Endocr Rev       Date:  2016-07-26       Impact factor: 19.871

Review 10.  Melatonin for cognitive impairment.

Authors:  S L Jansen; D A Forbes; V Duncan; D G Morgan
Journal:  Cochrane Database Syst Rev       Date:  2006-01-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.